CLINICAL_TRIALS
trial_result
· 2022-03-21
Clinical Trial Update: DAHANCA 27 Transoral Laser Microsurgery for T1a Glottic Cancer [Phase 2]
Summary
Phase 2 trial update for transoral laser microsurgery in T1a glottic cancer within head and neck squamous cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Danish Head and Neck Cancer Group | Conditions: Head and Neck Squamous Cell Carcinoma, Glottic T1 | Phase 2 | Status: UNKNOWN